PhaseRx Price Prediction
| PZRXQDelisted Stock | USD 0.0002 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using PhaseRx hype-based prediction, you can estimate the value of PhaseRx from the perspective of PhaseRx response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in PhaseRx to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying PhaseRx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PhaseRx after-hype prediction price | USD 2.5E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PhaseRx |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PhaseRx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PhaseRx After-Hype Price Prediction Density Analysis
As far as predicting the price of PhaseRx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PhaseRx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of PhaseRx, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PhaseRx Estimiated After-Hype Price Volatility
In the context of predicting PhaseRx's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PhaseRx's historical news coverage. PhaseRx's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered PhaseRx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PhaseRx is very steady at this time. Analysis and calculation of next after-hype price of PhaseRx is based on 3 months time horizon.
PhaseRx Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as PhaseRx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PhaseRx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PhaseRx, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0002 | 0.0003 | 25.00 |
|
PhaseRx Hype Timeline
PhaseRx is at this time traded for 0.0002. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. PhaseRx is anticipated to increase in value after the next headline, with the price projected to jump to 2.5E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price gain on the next news is estimated to be 25.0%, whereas the daily expected return is at this time at 0.0%. The volatility of related hype on PhaseRx is about 0.0%, with the expected price after the next announcement by competition of 0.00. PhaseRx has accumulated 5.13 M in total debt. PhaseRx has a current ratio of 2.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist PhaseRx until it has trouble settling it off, either with new capital or with free cash flow. So, PhaseRx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PhaseRx sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PhaseRx to invest in growth at high rates of return. When we think about PhaseRx's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next anticipated press release will be within a week. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.PhaseRx Related Hype Analysis
Having access to credible news sources related to PhaseRx's direct competition is more important than ever and may enhance your ability to predict PhaseRx's future price movements. Getting to know how PhaseRx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PhaseRx may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORTX | Orchard Therapeutics PLC | 0.00 | 0 per month | 3.03 | 0 | 5.13 | (5.03) | 27.90 | |
| SLRX | Salarius Pharmaceuticals | (0.17) | 3 per month | 0.00 | (0.03) | 9.59 | (9.15) | 27.43 | |
| MRKR | Marker Therapeutics | (0.10) | 1 per month | 6.03 | 0.01 | 9.72 | (11.56) | 37.38 | |
| FBRX | Forte Biosciences | 0.38 | 5 per month | 2.96 | 0.14 | 9.70 | (6.07) | 128.00 | |
| INFI | Infinity Pharmaceuticals | 0.01 | 1 per month | 8.66 | (0.0006) | 13.33 | (12.50) | 50.00 |
PhaseRx Additional Predictive Modules
Most predictive techniques to examine PhaseRx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PhaseRx using various technical indicators. When you analyze PhaseRx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PhaseRx Predictive Indicators
The successful prediction of PhaseRx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PhaseRx, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PhaseRx based on analysis of PhaseRx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PhaseRx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PhaseRx's related companies.
Story Coverage note for PhaseRx
The number of cover stories for PhaseRx depends on current market conditions and PhaseRx's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PhaseRx is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PhaseRx's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in PhaseRx Pink Sheet
If you are still planning to invest in PhaseRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseRx's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |